Internal Medicine · Des Moines, IA
NPI
1396724167
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
7
Medicare group memberships
Hospitals
2
Hospital affiliations
1221 Pleasant St, Suite 200
Des Moines, IA, 50309
Phone (515) 241-8222
Groups this clinician bills Medicare through
Medicare paid, 2024
$259K
5,462 services
Medicare patients, 2024
1,104
Average age 81
Drug cost, 2024
$3.3M
52,104 prescriptions
Company payments, 2024
$74.95
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael P O'Conner was code 99490 (chronic, principal, and transitional care management), 538 times for 71 patients. In total Michael P O'Conner billed 5,462 services in 55 codes, and Medicare paid $259K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-27.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 538 | 71 | $43.75 | $24K |
| 99306 SNF E&M | Facility | 429 | 386 | $130.91 | $56K |
| 99305 SNF E&M | Facility | 386 | 344 | $94.83 | $37K |
| 36415 Venipuncture Blood Collection | Office | 336 | 194 | $8.61 | $2,892 |
| 99214 Office E&M - Established | Office | 321 | 195 | $77.64 | $25K |
| 99454 E&M - Miscellaneous | Office | 313 | 36 | $30.59 | $9,575 |
| 99457 E&M - Miscellaneous | Office | 233 | 38 | $32.63 | $7,603 |
| 99309 SNF E&M | Office | 171 | 70 | $78.81 | $13K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 170 | 170 | $118.92 | $20K |
| 99308 SNF E&M | Office | 134 | 45 | $54.78 | $7,341 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 119 | 84 | $11.69 | $1,391 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 119 | 45 | $33.78 | $4,020 |
| 99305 SNF E&M | Office | 102 | 102 | $92.07 | $9,391 |
| 91322 Vaccine Product | Office | 64 | 56 | $145.04 | $9,282 |
| 90480 Vaccine Administration | Office | 64 | 56 | $38.68 | $2,476 |
By year: 2022 $175K for 3,336 services; 2023 $181K for 2,669 services; 2024 $259K for 5,462 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 336 | 194 | $8.61 | $2,892 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael P O'Conner prescribed most often to Medicare patients was Levothyroxine Sodium, with 2,653 prescriptions and refills. In total Michael P O'Conner wrote 52,104 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 2,653 | 3,033 | 299 | $27K |
| Atorvastatin Calcium Generic | 2,338 | 3,041 | 407 | $32K |
| Furosemide Generic | 1,857 | 1,920 | 267 | $14K |
| Sertraline Hcl Generic | 1,591 | 1,670 | 220 | $21K |
| Amlodipine Besylate Generic | 1,550 | 1,936 | 265 | $15K |
| Eliquis Apixaban | 1,524 | 1,545 | 153 | $476K |
| Gabapentin Generic | 1,424 | 1,517 | 213 | $27K |
| Metoprolol Succinate Generic | 1,018 | 1,165 | 181 | $18K |
| Memantine Hcl Generic | 979 | 1,016 | 126 | $38K |
| Lisinopril Generic | 926 | 1,063 | 163 | $11K |
| Potassium Chloride Generic | 921 | 960 | 158 | $22K |
| Donepezil Hcl Generic | 867 | 942 | 119 | $13K |
| Tamsulosin Hcl Generic | 865 | 1,051 | 141 | $19K |
| Omeprazole Generic | 850 | 1,192 | 183 | $12K |
| Losartan Potassium Generic | 833 | 1,247 | 157 | $9,397 |
Brand drugs: 8,622 claims; generic drugs: 43,209 claims; opioid claims: 501.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Michael P O'Conner $74.95 ($74.95 in general payments such as food, travel and fees) from 2 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $49.17.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.